Effects of a diabetes-specific enteral nutrition on nutritional and immune status of diabetic, obese, and endotoxemic rats: Interest of a graded arginine supply

Critical Care Medicine

Volumn 40, Issue 8, 2012, Pages 2423-2430

  Breuillard, Charlotte ^a   Darquy, Sylviane ^a   Curis, Emmanuel ^b   Neveux, Nathalie ^a,c   Garnier, Jean Pierre ^a   Cynober, Luc ^a,c   De Bandt, Jean Pascal ^a,c  

^a Laboratoire de Biomathématiques   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

arginine; diabetes; endotoxin and lipopolysaccharide; enteral nutrition; obesity; peritoneal macrophages

Indexed keywords

ALANINE; ALBUMIN; ALPHA 2 GLOBULIN; ARGINASE 1; ARGININE; ASPARAGINE; CHOLESTEROL; CITRULLINE; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HISTIDINE; IMMUNOGLOBULIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; LYSINE; METHIONINE; NITRIC OXIDE; ORNITHINE; PREALBUMIN; PROLINE; SERINE; THREONINE; TUMOR NECROSIS FACTOR ALPHA; TYROSINE; VALINE;

ALBUMIN BLOOD LEVEL; AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENDOTOXEMIA; ENTERIC FEEDING; GLUCOSE BLOOD LEVEL; IMMUNE STATUS; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SURVIVAL RATE; ZUCKER DIABETIC FATTY RAT;

ANIMALS; ARGININE; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; ENDOTOXEMIA; ENTERAL NUTRITION; FOOD, FORMULATED; INSULIN; MACROPHAGES; MALE; NITRIC OXIDE; NUTRITIONAL STATUS; OBESITY; RATS; RATS, ZUCKER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864284910     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31825334da     Document Type: Article

References (55)

1. Chan RS, Woo J: Prevention of overweight and obesity: How effective is the current public health approach. Int J Environ Res Public Health 2010; 7:765-783.
2. Falagas ME, Kompoti M: Obesity and infection. Lancet Infect Dis 2006; 6:438-446.
3. Carton JA, Maradona JA, Nuño FJ, et al: Diabetes mellitus and bacteraemia: A comparative study between diabetic and non-diabetic patients. Eur J Med 1992; 1:281-287.
4. Shah BR, Hux JE: Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003; 26:510-513. (Pubitemid 36929083)
5. Strandberg L, Verdrengh M, Enge M, et al: Mice chronically fed high-fat diet have increased mortality and disturbed immune response in sepsis. PLoS ONE 2009; 4:e7605.
6. Geerlings SE, Hoepelman AI: Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999; 26:259-265.
7. Andreasen AS, Pedersen-Skovsgaard T, Berg RM, et al: Type 2 diabetes mellitus is associated with impaired cytokine response and adhesion molecule expression in human endotoxemia. Intensive Care Med 2010; 36:1548-1555.
8. Zykova SN, Jenssen TG, Berdal M, et al: Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes 2000; 49:1451-1458.
9. Breuillard C, Belabed L, Bonhomme S, et al: Arginine availability modulates arginine metabolism and TNF? production in peritoneal macrophages from Zucker diabetic fatty rats. Clin Nutr 2011; doi:10.1016/j.clnu.2011.11.012.
10. Blanc MC, Moinard C, Béziel A, et al: Arginine and glutamine availability and macrophage functions in the obese insulin-resistant Zucker rat. J Cell Physiol 2005; 202:153-159. (Pubitemid 39603372)
11. Clement S, Braithwaite SS, Magee MF, et al; American Diabetes Association Diabetes in Hospitals Writing Committee: Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004; 27:553-591. (Pubitemid 38174086)
12. Tseng CC, Hattori Y, Kasai K, et al: Decreased production of nitric oxide by LPS-treated J774 macrophages in high-glucose medium. Life Sci 1997; 60:PL99-P106.
13. Perner A, Nielsen SE, Rask-Madsen J: High glucose impairs superoxide production from isolated blood neutrophils. Intensive Care Med 2003; 29:642-645. (Pubitemid 36523682)
14. Bouter KP, Meyling FH, Hoekstra JB, et al: Influence of blood glucose levels on peripheral lymphocytes in patients with diabetes mellitus. Diabetes Res 1992; 19:77-80.
15. Belabed L, Senon G, Blanc MC, et al: The equivocal metabolic response to endotoxaemia in type 2 diabetic and obese ZDF rats. Diabetologia 2006; 49:1349-1359.
16. Wu G, Bazer FW, Davis TA, et al: Arginine metabolism and nutrition in growth, health and disease. Amino Acids 2009; 37:153-168.
17. Popovic PJ, Zeh HJ 3rd, Ochoa JB: Arginine and immunity. J Nutr 2007; 137(6 Suppl 2):1681S-1686S. (Pubitemid 46855530)
18. Luiking YC, Poeze M, Ramsay G, et al: The role of arginine in infection and sepsis. JPEN J Parenter Enteral Nutr 2005; 29(Suppl 1):S70-S74.
19. Heyland DK, Novak F, Drover JW, et al: Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001; 286:944-953. (Pubitemid 33010341)
20. Bantle JP, Wylie-Rosett J, Albright AL, et al; American Diabetes Association: Nutrition recommendations and interventions for diabetes: A position statement of the American Diabetes Association. Diabetes Care 2008; 31 (Suppl 1):S61-S78.
21. Mann JI, De Leeuw I, Hermansen K, et al; Diabetes and Nutrition Study Group (DNSG) of the European Association: Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis 2004; 14:373-394. (Pubitemid 40459260)
22. Monnier L, Slama G, Vialettes B, Ziegler O: Nutrition et Diabète, 1995. http://www.alfediam.org/membres/recommandations/alfediam-nutrition- diabete.asp. Accessed May 9, 2012.
23. Agence française de sécurité sanitaire des aliments (AFSSA). Actualisation des apports nutritionnels conseillés pour les acides gras [Actualisation of recommended dietary allowance for fatty acids] 2010; saisine n 2006-SA-0359.
24. Elia M, Ceriello A, Laube H, et al: Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: A systematic review and meta-analysis. Diabetes Care 2005; 28:2267-2279. (Pubitemid 41242484)
25. Pohl M, Mayr P, Mertl-Roetzer M, et al: Glycaemic control in type II diabetic tube-fed patients with a new enteral formula low in carbohydrates and high in monounsaturated fatty acids: A randomised controlled trial. Eur J Clin Nutr 2005; 59:1221-1232. (Pubitemid 41655626)
26. Mesejo A, Acosta JA, Ortega C, et al: Comparison of a high-protein disease-specific enteral formula with a high-protein enteral formula in hyperglycemic critically ill patients. Clin Nutr 2003; 22:295-305. (Pubitemid 36701646)
27. Unger RH: How obesity causes diabetes in Zucker diabetic fatty rats. Trends Endocrinol Metab 1997; 8:276-282. (Pubitemid 27424205)
28. Plotkin BJ, Paulson D, Chelich A, et al: Immune responsiveness in a rat model for type II diabetes (Zucker rat, fa/fa): Susceptibility to Candida albicans infection and leucocyte function. J Med Microbiol 1996; 44:277-283. (Pubitemid 26153290)
29. Osowska S, Moinard C, Neveux N, et al: Citrulline increases arginine pools and restores nitrogen balance after massive intestinal resection. Gut 2004; 53:1781-1786. (Pubitemid 39556896)
30. Liu SF, Barnes PJ, Evans TW: Time course and cellular localization of lipopolysaccharide-induced inducible nitric oxide synthase messenger RNA expression in the rat in vivo. Crit Care Med 1997; 25:512-518. (Pubitemid 27152748)
31. Bonhomme S, Belabed L, Blanc M C, et al: The effect of arginine-supplemented enteral nutrition on macrophages from endotoxemic obese and type 2 diabetic rats [abstract]. J Parenter Enteral Nutr 2007; 31:S1-S70.
32. Michie HR, Manogue KR, Spriggs DR, et al: Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318:1481-1486.
33. Fleury P, Eberhard R: [Determination of proteins by photometric, biuret method, according to the technique of Gornall]. Ann Biol Clin (Paris) 1951; 9:453-466.
34. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2011. Available at: http://www.R-project.org/. Accessed February 7, 2012.
35. Hsu JC: Multiple Comparisons: Theory and Methods. First edition. London, Chapman and Hall/CRC, 1996.
36. Victor VM, De La Fuente M: Changes in the superoxide production and other macrophage functions could be related to the mortality of mice with endotoxin-induced oxidative stress. Physiol Res 2003; 52:101-110. (Pubitemid 36356267)
37. Dasu MR, Jialal I: Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors. Am J Physiol Endocrinol Metab 2011; 300:E145-E154.
38. Calder PC: The 2008 ESPEN Sir David Cuthbertson Lecture: Fatty acids and inflammation-from the membrane to the nucleus and from the laboratory bench to the clinic. Clin Nutr 2010; 29:5-12.
39. Pittet YK, Berger MM, Pluess TT, et al: Blunting the response to endotoxin in healthy subjects: Effects of various doses of intravenous fish oil. Intensive Care Med 2010; 36:289-295.
40. Zhang LT, Yao YM, Lu JQ, et al: Sodium butyrate prevents lethality of severe sepsis in rats. Shock 2007; 27:672-677.
41. Fernandes D, Sordi R, Pacheco LK, et al: Late, but not early, inhibition of soluble guanylate cyclase decreases mortality in a rat sepsis model. J Pharmacol Exp Ther 2009; 328:991-999.
42. Chen SJ, Li SY, Shih CC, et al: NO contributes to abnormal vascular calcium regulation and reactivity induced by peritonitis-associated septic shock in rats. Shock 2010; 33:473-478.
43. Lopez S, Bermudez B, Ortega A, et al: Effects of meals rich in either monounsaturated or saturated fat on lipid concentrations and on insulin secretion and action in subjects with high fasting triglyceride concentrations. Am J Clin Nutr 2011; 93:494-499.
44. González-Périz A, Horrillo R, Ferré N, et al: Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: A role for resolvins and protectins. FASEB J 2009; 23:1946-1957.
45. Riediger ND, Othman R, Fitz E, et al: Low n-6:n-3 fatty acid ratio, with fish-or flaxseed oil, in a high fat diet improves plasma lipids and beneficially alters tissue fatty acid composition in mice. Eur J Nutr 2008; 47:153-160.
46. Kashyap SR, Lara A, Zhang R, et al: Insulin reduces plasma arginase activity in type 2 diabetic patients. Diabetes Care 2008; 31:134-139.
47. Fu WJ, Haynes TE, Kohli R, et al: Dietary L-arginine supplementation reduces fat mass in Zucker diabetic fatty rats. J Nutr 2005; 135:714-721. (Pubitemid 40464093)
48. Jobgen W, Meininger CJ, Jobgen SC, et al: Dietary L-arginine supplementation reduces white fat gain and enhances skeletal muscle and brown fat masses in diet-induced obese rats. J Nutr 2009; 139:230-237.
49. West MA, Koons A: Endotoxin tolerance in sepsis: Concentration-dependent augmentation or inhibition of LPS-stimulated macrophage TNF secretion by LPS pretreatment. J Trauma 2008; 65:893-898; discussion 898.
50. Lumeng CN, Bodzin JL, Saltiel AR: Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117:175-184. (Pubitemid 46048464)
51. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, et al: Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007; 447:1116-1120. (Pubitemid 47014427)
52. Lefèvre L, Galès A, Olagnier D, et al: PPAR? ligands switched high fat diet-induced macrophage M2b polarization toward M2a thereby improving intestinal Candida elimination. PLoS ONE 2010; 5:e12828.
53. Yeramian A, Martin L, Arpa L, et al: Macrophages require distinct arginine catabolism and transport systems for proliferation and for activation. Eur J Immunol 2006; 36:1516-1526. (Pubitemid 43942140)
54. Assumpçäo CR, Brunini TM, Pereira NR, et al: Insulin resistance in obesity and metabolic syndrome: Is there a connection with platelet l-arginine transport? Blood Cells Mol Dis 2010; 45:338-342.
55. Schwartz IF, Ingbir M, Chernichovski T, et al: Arginine uptake is attenuated, through post-translational regulation of cationic amino acid transporter-1, in hyperlipidemic rats Atherosclerosis 2007; 194:357-363 (Pubitemid 47513099)